✦ LIBER ✦

Des lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate

✍ Scribed by Barry S. Stein; Joseph A. Smith Jr

Book ID: 119045525
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 419 KB
Volume: 25
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(85)90484-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

247 Treatment with luteinizing-hormone r

247 Treatment with luteinizing-hormone releasing-hormone analog in patients with prostatic carcinoma

✍ G. Mathé; A.V. Schally; M.L. Vo Van; J.L. Misset; D. Machover; M. Musset; T. Dor 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Zoladex (ICI 118,630): Clinical trial of

Zoladex (ICI 118,630): Clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma

✍ G.P. Murphy; J.M. Greco; J.L. Chin; R.P. Huben; M. Scott; H.A. deHaan 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Receptors for Prolactin, Somatostatin, a

Receptors for Prolactin, Somatostatin, and Luteinizing Hormone-Releasing Hormone in Experimental Prostate Cancer after Treatment with Analogs of Luteinizing Hormone-Releasing Hormone and Somatostatin

✍ T. Kadar, T. W. Redding, M. Ben-David and A. V. Schally 📂 Article 📅 1988 🏛 National Academy of Sciences 🌐 English ⚖ 787 KB

Somatostatin Analogs as Adjuncts to Agon

Somatostatin Analogs as Adjuncts to Agonists of Luteinizing Hormone-Releasing Hormone in the Treatment of Experimental Prostate Cancer

✍ A. V. Schally and T. W. Redding 📂 Article 📅 1987 🏛 National Academy of Sciences 🌐 English ⚖ 1014 KB

Luteinizing hormone-releasing hormone (L

Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma

✍ Gerald W. Chodak 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Bone fractures associated with luteinizi

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

✍ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f